Fourpath Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-648
| Closed | -$126K | – | 291 |
|
|
2024
Q3 | $126K | Sell |
648
-281
| -30% | -$54.5K | 0.02% | 259 |
|
|
2024
Q2 | $215K | Sell |
929
-106
| -10% | -$24.6K | 0.16% | 122 |
|
|
2024
Q1 | $223K | Sell |
1,035
-53
| -5% | -$11.4K | 0.15% | 128 |
|
|
2023
Q4 | $282K | Sell |
1,088
-15
| -1% | -$3.88K | 0.19% | 97 |
|
|
2023
Q3 | $283K | Sell |
1,103
-29
| -3% | -$7.45K | 0.21% | 94 |
|
|
2023
Q2 | $322K | Sell |
1,132
-20
| -2% | -$5.7K | 0.39% | 70 |
|
|
2023
Q1 | $320K | Buy |
1,152
+1
| +0.1% | +$278 | 0.22% | 97 |
|
|
2022
Q4 | $319K | Sell |
1,151
-221
| -16% | -$61.2K | 0.23% | 90 |
|
|
2022
Q3 | $366K | Sell |
1,372
-272
| -17% | -$72.6K | 0.25% | 80 |
|
|
2022
Q2 | $335K | Sell |
1,644
-288
| -15% | -$58.7K | 0.21% | 101 |
|
|
2022
Q1 | $407K | Sell |
1,932
-1
| -0.1% | -$211 | 0.16% | 106 |
|
|
2021
Q4 | $464K | Buy |
+1,933
| New | +$464K | 0.18% | 98 |
|